Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
EDSS variability before randomization may limit treatment discovery in primary progressive MS.
Zhang J, Waubant E, Cutter G, Wolinsky JS, Glanzman R.
Mult Scler. 2013 May;19(6):775-81. doi: 10.1177/1352458512459685. Epub 2012 Oct 1.
Related citations
Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial.
Hawker K, O'Connor P, Freedman MS, Calabresi PA, Antel J, Simon J, Hauser S, Waubant E, Vollmer T, Panitch H, Zhang J, Chin P, Smith CH; OLYMPUS trial group.
Ann Neurol. 2009 Oct;66(4):460-71. doi: 10.1002/ana.21867.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on